Family communication tool for kids getting transplant or cell therapy
Part of Blood & lymphatic, Cancer, Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at a family communication tool for children and teens getting stem cell transplants or cellular therapy. It helps families talk about treatment together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The child is between 8 and 17 years old.
- The child has been referred for a stem cell transplant or cellular therapy.
- The child can understand English and can talk about their feelings.
- A parent or guardian who makes medical decisions for the child can also take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses one-on-one interviews to learn what families and clinicians need to make decisions about gene therapy for rare diseases. The goal is to create or improve decision tools that make gene therapy information easier to understand and act on.
This study tests a special stem cell transplant for children and young adults with certain high-risk blood cancers or bone marrow diseases. It uses a half-matched family donor and a technique to remove specific cells, which may lower the risk of side effects and help the body accept the new cells.
This study tests a structured set of conversations about future medical care (advance care planning) for adolescents and young adults who are preparing for a stem cell transplant. It also involves a caregiver (and the care team) to help ensure the discussions are understood, documented, and completed at the right times.
This trial looks at whether a personalized goal-setting tool helps children and teens recovering from a stem cell transplant. It is designed for young patients with cancer or blood disorders who are not already in rehab.
This study looks at how CAR T-cell treatment affects thinking, learning, and day-to-day brain function in children and young adults with certain blood cancers. You (and a caregiver) may complete online testing so researchers can track these changes over time and whether support is needed.
This study tests a digital health app to help you manage symptoms and stay connected with your care team while receiving CAR-T therapy as an outpatient. It's designed for people with blood cancers who have a caregiver living with them.
Hear when a new Hematologic Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.